227 filings
Page 2 of 12
8-K
7t87cq
7 Mar 23
FRTX-02 was generally safe and well tolerated within the potential therapeutic dose range, meeting the study’s primary objectives
5:04pm
8-K
vuts8sd
24 Feb 23
Departure of Directors or Certain Officers
4:12pm
8-K/A
vim279habw
22 Feb 23
Departure of Directors or Certain Officers
4:04pm
8-K
uk7t womxfytn0
7 Feb 23
Departure of Directors or Certain Officers
5:05pm
8-K
axlfe
27 Jan 23
Fresh Tracks Therapeutics Appoints Andrew Sklawer as Chief Executive Officer
4:06pm
8-K
bktbw gak
10 Nov 22
Fresh Tracks Therapeutics Reports Third Quarter 2022
4:10pm
8-K
g1q1g77dsuyh9rcwxgha
20 Sep 22
Departure of Directors or Certain Officers
4:48pm
8-K
kw3c95vaulaemp1zuc6
8 Sep 22
Amendments to Articles of Incorporation or Bylaws
8:01am
8-K
f1b0m45r
1 Sep 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:02pm
8-K
adjzubiqozom87
23 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
zpdvtef1m7ul fzv6
11 Aug 22
Brickell Biotech Reports Second Quarter 2022
4:09pm
8-K
msi6c7fan uc
29 Jul 22
Departure of Directors or Certain Officers
4:07pm
8-K
h2qbwmt04 4kw8coq
20 Jul 22
Other Events
8:03am
8-K
bwjge3rf
5 Jul 22
Brickell Biotech Announces 1-For-45 Reverse Stock Split
4:06pm
8-K
lpk8gmn
15 Jun 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:01am
8-K
qfx9qr1l4t5584m1b01
7 Jun 22
Departure of Directors or Certain Officers
4:24pm
8-K
zqf5k6gcq l504o
25 May 22
Entry into a Material Definitive Agreement
4:16pm
8-K
efvw l964ov844ihvn
17 May 22
Departure of Directors or Certain Officers
4:14pm
8-K
dc2gke
12 May 22
Brickell Biotech Reports First Quarter 2022
4:05pm
8-K
i5sk5
3 May 22
Brickell Biotech Announces Adjournment of Annual Meeting of Stockholders
4:15pm